1. Home
  2. OXBR vs FEMY Comparison

OXBR vs FEMY Comparison

Compare OXBR & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OXBR
  • FEMY
  • Stock Information
  • Founded
  • OXBR 2013
  • FEMY 2004
  • Country
  • OXBR Cayman Islands
  • FEMY United States
  • Employees
  • OXBR N/A
  • FEMY N/A
  • Industry
  • OXBR Property-Casualty Insurers
  • FEMY Medical/Dental Instruments
  • Sector
  • OXBR Finance
  • FEMY Health Care
  • Exchange
  • OXBR Nasdaq
  • FEMY Nasdaq
  • Market Cap
  • OXBR 16.9M
  • FEMY 18.6M
  • IPO Year
  • OXBR 2014
  • FEMY 2021
  • Fundamental
  • Price
  • OXBR $1.99
  • FEMY $0.38
  • Analyst Decision
  • OXBR Strong Buy
  • FEMY Strong Buy
  • Analyst Count
  • OXBR 1
  • FEMY 3
  • Target Price
  • OXBR $5.00
  • FEMY $7.33
  • AVG Volume (30 Days)
  • OXBR 42.6K
  • FEMY 1.6M
  • Earning Date
  • OXBR 08-14-2025
  • FEMY 08-08-2025
  • Dividend Yield
  • OXBR N/A
  • FEMY N/A
  • EPS Growth
  • OXBR N/A
  • FEMY N/A
  • EPS
  • OXBR N/A
  • FEMY N/A
  • Revenue
  • OXBR $1,983,000.00
  • FEMY $1,887,016.00
  • Revenue This Year
  • OXBR $497.99
  • FEMY $103.55
  • Revenue Next Year
  • OXBR $42.14
  • FEMY $148.13
  • P/E Ratio
  • OXBR N/A
  • FEMY N/A
  • Revenue Growth
  • OXBR N/A
  • FEMY 98.61
  • 52 Week Low
  • OXBR $1.27
  • FEMY $0.31
  • 52 Week High
  • OXBR $5.81
  • FEMY $1.80
  • Technical
  • Relative Strength Index (RSI)
  • OXBR 54.65
  • FEMY 24.33
  • Support Level
  • OXBR $1.93
  • FEMY $0.36
  • Resistance Level
  • OXBR $2.30
  • FEMY $0.42
  • Average True Range (ATR)
  • OXBR 0.19
  • FEMY 0.06
  • MACD
  • OXBR 0.03
  • FEMY -0.01
  • Stochastic Oscillator
  • OXBR 47.26
  • FEMY 16.48

About OXBR Oxbridge Re Holdings Limited

Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: